Navigation Links
Solos Endoscopy Reports Full Year 2012 Results
Date:5/15/2013

BOSTON, May 15, 2013 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, reported sales and earnings results for the full year ended December 31, 2012.

In addition, the Company's President, Robert Segersten , posted a Letter to Shareholders outlining recent announcements and updates on the Company's progress as it relates to its product lines and pursuit of ISO 13485 certification and CE Mark for its MammoView® devices.

The Company's financial results, disclosure statement and President's Letter can be found on the OTC Markets website (http://www.otcmarkets.com/stock/SNDY/financials).

About Solos Endoscopy, Inc.:

Solos Endoscopy is celebrating its 25th Year of providing quality innovative healthcare instruments to Hospitals across the Country. For more than 25 Years, from medical schools to hospitals, surgeons have trusted Solos Endoscopy to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.

For more information on TUV SUD America visit www.tuvamerica.com

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the company's Annual Report filing and other filings with the OTC Markets Group (available at www.otcmarkets.com). The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.

Source: Solos Endoscopy, Inc.
Investor Relations
(617) 360-9719


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy Reduces Liabilities by More than $570,000
2. Solos Endoscopys Bariatric Instruments Are Now Available
3. Solos Endoscopy Posts Total Assets of $2,426,883 for Period Ended June 30, 2012
4. Solos Endoscopy Sales Increase by More than 35% for the Month of October
5. Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
6. Solos Endoscopy and TUV SUD America Schedule Stage 1 ISO 13485 Audit for February 26, 2013
7. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
8. Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive Disease Week ®
9. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
10. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
11. Asia Pacific Endoscopy Devices Industry is Expected to Reach USD 3.4 Billion in 2017: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 18, 2017  ViewRay, Inc. (Nasdaq: ... first and only clinical MRI-guided radiation therapy system, announced ... of approximately $26.1 million through a private placement ... Management led the financing and was joined by ... LLC and Kearny Venture Partners, and an additional ...
(Date:1/19/2017)... , Jan. 18, 2017 The drug ... billion by 2021 from USD 1,179.20 billion in 2016, ... Increasing prevalence of chronic diseases, increasing demand for ... factors driving the growth of this market. Whereas, self-administration ... generic drugs offer significant growth opportunities for players operating ...
(Date:1/18/2017)... 18, 2017  Aprima Medical Software, a leading ... management (PM) and revenue cycle management (RCM) solutions ... a former reseller Healthcare Data Solutions (HDS) of ... Aprima will assume full support for HDS,s customers, ... practices across 15 states. Financial terms were not ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... 2017 , ... “The Angel”: a heartwarming and earnest tale of faith ... his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former ... impassioned writer. , When asked of her new book, Marjorie says, “‘The Angel’ was ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches ... Kimberly Cordoves, a mother of three in Oklahoma City, and a devoted woman of faith. ... a book has been in the back of my mind for years, but actually doing ...
(Date:1/19/2017)... ... January 19, 2017 , ... Aerolib ... system for Clinical and Regulatory education for Physicians, Physician Advisors, Case managers, ... education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning Management ...
(Date:1/19/2017)... ... 19, 2017 , ... LabRoots , the leading provider ... world, announces the launch of its newly redesigned website. The sleek new design ... and trending news, vital information on upcoming virtual events and webinars, all while ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery solutions to ...
Breaking Medicine News(10 mins):